acitretin has been researched along with Cancer of Skin in 124 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (3.23) | 18.7374 |
1990's | 17 (13.71) | 18.2507 |
2000's | 45 (36.29) | 29.6817 |
2010's | 40 (32.26) | 24.3611 |
2020's | 18 (14.52) | 2.80 |
Authors | Studies |
---|---|
Bollag, W; Buck, M; Cheung, HC; Han, RJ; Hansen, R; Ineichen, U; Pawson, BA; Pleil, H; Rüegg, R; Trown, PW | 1 |
Bohoslawec, O; Chan, KK; DeNoble, J; Gabriel, E; Han, RJ; Machlin, LJ; Pawson, BA; Piermattie, V; Specian, AC; Srisethnil, S; Trown, PW | 1 |
Allnutt, KJ; Brennand, S; Chong, AH; Davenport, R; Goh, MS; Li, J; Vogrin, S | 1 |
Chen, B; Jiang, B; Li, D; Liu, X; Yang, L; Ye, T; Yu, B; Zou, Y | 1 |
Aquino, C; Avallone, G; Boskovic, S; Fava, P; Macagno, N; Quaglino, P; Ribero, S; Roccuzzo, G | 1 |
Farah, J; Farah, R; Weingarten, M | 1 |
Dev, PP; Verma, P | 1 |
Amitay-Laish, I; Barzilai, A; Ben Amitai, D; Davidovici, B; Didkovsky, E; Friedland, R; Greenberger, S; Hodak, E; Landov, H; Ollech, A; Prag Naveh, H | 1 |
Ahearn, I; Gutierrez, D; Latkowski, JA; Obijiofor, C; Shvartsbeyn, M; Yin, E | 1 |
Guzman, AK; Ruiz, ES; Schmults, CD | 1 |
Good, AJ; Herold, M; Longo, MI; Nielson, CB | 1 |
Chlouverakis, G; Economidi, A; Georgiou, E; Kavvalou, E; Koletsa, T; Kruger-Krasagakis, SE; Nikolaou, V; Papadavid, E; Patsatsi, A; Rigopoulos, D; Sidiropoulou, P; Stratigos, AJ | 1 |
Badri, O; Karia, PS; Ruiz, ES; Schmults, CD | 1 |
Oh, CC; Sultana, R; Tam, SYC; Tee, LY | 1 |
Bunch, C; Jäger, M; Schmitt, J; Valipour, A; Weberschock, T; Wu, P | 1 |
Bedier, H; Julien, LA; Lin, J; Routy, JP | 1 |
Landow, SM; Lim, RK; Weinstock, MA | 1 |
Hoegler, KM; Khachemoune, A | 1 |
Arzeno, J; Kim, J; Leavitt, E; Lonowski, S | 1 |
Bata, B; Currie, Z; Salvi, S; Tan, J; Wang, H | 1 |
Davidovici, B; Hodak, E; Reiss-Huss, S; Solomon-Cohen, E | 1 |
Kaffenberger, BH; Tian, F; Vaynshtok, PM | 1 |
Baykal, C; Sun, GP; Yazganoğlu, KD | 1 |
Baniandrés-Rodríguez, O; Conde-Montero, E; Horcajada-Reales, C; Parra-Blanco, V; Suárez-Fernández, R | 1 |
Chong, AH; Howard, MD; Su, JC | 1 |
Koh, WL; Oon, HH; Tan, WP | 1 |
Amitay-Laish, I; Hodak, E; Kershenovich, R; Prag-Naveh, H; Reiter, O | 1 |
Corry, A; Skillen, LA | 1 |
Mortimore, R; Sander, C; Shao, EX; Wheller, L | 1 |
Hu, HM; Li, YM; Liu, Q; Ma, H; Xu, H | 1 |
Abdolkarimi, B; Aslani, FS; Karimi, M; Mokhtari, M; Sepaskhah, M | 1 |
Cranmer, L; Curiel-Lewandrowski, C; Erickson, CP; LaPresto, L; Morrison, L | 1 |
Daniilidis, K; Lahner, M; Lahner, N; Lichtinger, TK; Teske, W; von Engelhardt, LV; von Schulze Pellengahr, C | 1 |
Chong, AH; Cumming, S; Leung, V; Ng, JC | 1 |
Anforth, R; Blumetti, TC; Clements, A; Fernandez-Peñas, P; Kefford, R; Long, GV | 1 |
de Muret, A; Khashoggi, M; Machet, L; Samimi, M | 1 |
Chon, SY; Geddes, ER; Sambrano, BL | 1 |
Konda, S; O'Bryan, KW; Patel, VA; Ratner, D | 1 |
Chong, WS; Lim, JH; Lim, KS | 1 |
Butler, DF; Eduardo, C; Sutton, L | 1 |
Plaza, JA; Ravikumar, S; Schieke, SM; Troy, JL; Yu, J | 1 |
Hibler, BP; Johnson-Jahangir, H; Rossi, AM | 1 |
Chen, Z; Wu, JH; Zhang, X; Zhao, J | 1 |
Caglia, M; Hashemi, P; Kim, C; Shulman, K | 1 |
Chroni, E; Tsambaos, D | 1 |
Chen, HD; Chen, J; He, CD; Jiang, Y; Jin, X; Lin, XY; Liu, M; Wang, KB; Wang, YK; Wei, HC; Xiao, T | 1 |
Colsman, A; Renner, R; Sticherling, M | 1 |
Henderson, C; Kurien, A; Lee, S | 1 |
Anliker, M; Arnold, A; Binet, I; Hofbauer, GF; Hunger, R; Kempf, W; Laffitte, E; Lapointe, AC; Pascual, M; Pelloni, F; Serra, A | 1 |
Bowen, GM; Florell, SF; Hadley, JC; Hadley, ML; Tristani-Firouzi, P | 1 |
Bashir, SJ; Pichert, G; Robertson, SJ; Robson, A; Whittaker, S | 1 |
Bair, SM; Cherpelis, BS; Glass, LF; Marquez, C; Smithberger, E | 1 |
Farley-Loftus, R; Latkowski, JA; Mandal, R | 1 |
Delaney, T; Foxton, G | 1 |
Barysch, MJ; Dummer, R; Kamarashev, J; Lockwood, LL | 1 |
Aguayo, R; Baradad, M; Casanova, JM; Sanmartín, V | 1 |
Chiu, MW; Hillman, JD; Monroe, HR | 1 |
Dunn, LK; Feldman, SR; Gaar, LR; O'Neill, JL; Yentzer, BA | 1 |
Alberts, SR; Barton, DL; Diekmann, BB; Kadakia, KC; Limburg, PJ; Loprinzi, CL; Novotny, PJ; Otley, CC; Pittelkow, MR; Sloan, JA | 1 |
Dellavalle, R; Francis, SO; Gamble, RG; Mason, MN; Prado, R; Wing, G | 1 |
Batard, ML; Cribier, B; Guillaume, JC; Kleinclauss, I; Merklen-Djafri, C | 1 |
Arcese, A; Camplone, G; Carlesimo, M; Di Russo, PP; Gamba, A; La Pietra, M; Mari, E; Orsini, D | 1 |
Anforth, R; Blumetti, TC; Fernandez-Penas, P; Mohd Affandi, A | 1 |
Oakley, A; Simpkin, S | 1 |
Cheeley, J; DeLong, LK; Parker, SR; Sahn, RE | 1 |
Bettoli, V; Virgili, A; Zauli, S | 1 |
Hermes, E; Kapp, A; Körner, M; Liekenbröcker, T; Wedi, B | 1 |
Gordon, KB; McClure, SL; Valentine, J | 1 |
Bannister, KM; George, R; Mathew, TH; Russ, GR; Weightman, W | 1 |
Galbraith, AJ; McNamara, IR; Muir, J | 1 |
Agnew, KL; Bunker, CB | 1 |
Blokx, WA; de Jong, EM; de Wilde, PC; Ruiter, DJ; Smit, JV; van de Kerkhof, PC | 1 |
de Jong, EM; de Sévaux, RG; Hoitsma, AJ; Smit, JV; van de Kerkhof, PC | 1 |
Cocuroccia, B; Girolomoni, G; Gubinelli, E; Posteraro, P | 1 |
Carrasco, D; Lebwohl, M; Tannis, C | 1 |
Ingves, C; Jemec, GB | 1 |
Khandpur, S; Sharma, VK | 1 |
Creamer, D; Watson, K | 1 |
Blokx, WA; de Jong, EM; de Sévaux, RG; Hoitsma, AJ; Smit, JV; van de Kerkhof, PC | 1 |
Bouwes Bavinck, JN; De Graaf, YG; Euvrard, S | 1 |
Tan, SR; Tope, WD | 1 |
Atasoy, P; Birol, A; Bozdoethan, O; Erkek, E; Koçak, M | 1 |
Azevedo, LS; Carneiro, RV; Ianhez, LE; Rivitti, EA; Sotto, MN | 1 |
Chen, K; Craig, JC; Shumack, S | 1 |
Atkins, CL; Brown, VL; Cerio, R; Ghali, L; Harwood, CA; Proby, CM | 1 |
Lei, XB; Qiu, S; Ran, LW; Tan, SS; Wang, WJ; Zeng, WH | 1 |
Renner, R; Rytter, M; Sticherling, M | 1 |
Le, K; Lim, A; Morrow, C; Samaraweera, U; See, A | 1 |
Haustein, UF; Paasch, U | 1 |
Cai, SQ; Chen, LR; Zheng, M | 1 |
Lebwohl, M; Otley, CC; Stasko, T; Tope, WD | 1 |
Dobrić, I; Loncarić, D; Manola, I; Pasić, A; Rados, J | 1 |
Ho, HC; Hsu, HC; Huang, YH; Kuan, YZ; Kuo, TT | 1 |
Ansarin, H; Shaianfar, N; Tajziehchi, L | 1 |
Fangman, W; Hunzeker, CM; Latkowski, JA | 1 |
Abramovits, W; Cockerell, CJ; Larsen, F; Susa, JS | 1 |
Arnault, JP; Barbaud, A; Cuny, JF; Granel-Brocard, F; Petitpain, N; Schmutz, JL | 1 |
Son, SB; Son, SW; Song, HJ | 1 |
Lebwohl, M; Menter, MA; Riddle, C; Smith, EC | 1 |
Lens, M; Medenica, L | 1 |
Attard, N; Bunker, CB; Fearfield, L; Prasad, P; Schmulewitz, L; Thomas, HJ; Westaby, D | 1 |
Hamada, K; Kobayashi, K; Mori, M; Morita, E; Ninomiya, T; Okada, Y | 1 |
Bailey, RR; Davis, A; Macdonald, K; Yuan, ZF | 1 |
French, LE; Saurat, JH | 1 |
Bagot, M | 1 |
Bavinck, JN; Hermans, J; Tegzess, AM; ter Schegget, J; Tieben, LM; Van der Woude, FJ; Vermeer, BJ | 1 |
Bjerring, P; Brodthagen, U; Søgaard, H; Zachariae, H | 1 |
Czarnetzki, BM; Grabbe, J; Krüger-Krasagakes, S | 1 |
French, LE; Ramelet, AA; Saurat, JH | 1 |
Castanet, J; Lacour, JP; Ortonne, JP | 1 |
Chang, A; Kuligowski, ME; van de Kerkhof, PC | 1 |
Bergoend, H; Delaporte, E; Feingold, N; Janin, A; N'guyen-Mailfer, C; Piette, F; Savary, JB; Vasseur, F | 1 |
Feind-Koopmans, A; van de Kerkhof, PC | 1 |
Armstrong, DK; Burrows, D; Irvine, A; Mayne, EE; Walsh, MY | 1 |
de Rooij, MJ; van de Kerkhof, PC | 1 |
Henz, BM; Kühl, P; Luger, T; Otte, HG; Stadler, R; Sterry, W; Zwingers, T | 1 |
Baloğlu, H; Doğan, B; Harmanyeri, Y; Taşkapan, O | 1 |
McKenna, DB; Murphy, GM | 1 |
Artemi, P; Kossard, S | 1 |
Bräuninger, W; Enk, A; Knop, J; Zipprich, F | 1 |
Basaran, E; Ermis, O; Yerebakan, O; Yilmaz, E | 1 |
Burmester, GR; Dörner, T; Feist, E; Hiepe, F; Lukowsky, A; Stroehmann, A | 1 |
De Bersaques, J; Geerts, ML; Kint, A; Vandeghinste, N | 1 |
Baquey, A; Beylot, C; Bezian, JH; Bioulac, P; Bonnemaison, D; Carteyron, M; Doutre, MS | 1 |
15 review(s) available for acitretin and Cancer of Skin
Article | Year |
---|---|
Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.
Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Carcinoma, Squamous Cell; Dermatologic Agents; Dermatology; Evidence-Based Medicine; Graft Rejection; Humans; Immunosuppressive Agents; Isotretinoin; Keratosis, Actinic; Organ Transplantation; Skin Neoplasms; Transplant Recipients; Treatment Outcome; Warts | 2019 |
Efficacy and Cost Analysis for Acitretin for Basal and Squamous Cell Carcinoma Prophylaxis in Renal Transplant Recipients.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Costs and Cost Analysis; Humans; Keratolytic Agents; Kidney Transplantation; Skin Neoplasms; Transplant Recipients | 2021 |
Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Keratosis, Actinic; Niacinamide; Organ Transplantation; Randomized Controlled Trials as Topic; Skin Neoplasms; Transplant Recipients; Treatment Outcome | 2021 |
Interventions for mycosis fungoides.
Topics: Acitretin; Antineoplastic Agents; Bexarotene; Combined Modality Therapy; Humans; Immunologic Factors; Interferon-alpha; Mycosis Fungoides; Neoplasm Staging; Photochemotherapy; Photopheresis; PUVA Therapy; Randomized Controlled Trials as Topic; Skin Neoplasms | 2020 |
Skin Cancer Following Solid Organ Transplantation: A Review of Risk Factors and Models of Care.
Topics: Acitretin; Humans; Immunosuppressive Agents; Keratolytic Agents; Organ Transplantation; Patient Education as Topic; Postoperative Complications; Prevalence; Risk Factors; Skin Neoplasms | 2018 |
Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients.
Topics: Acitretin; Anticarcinogenic Agents; Bexarotene; Humans; Risk; Skin Neoplasms; Tetrahydronaphthalenes | 2010 |
A case of verrucous psoriasis.
Topics: Acitretin; Administration, Topical; Adrenal Cortex Hormones; Aged, 80 and over; Alopecia; Diagnosis, Differential; Female; Humans; Keratosis, Seborrheic; Psoriasis; Recurrence; Skin Neoplasms | 2011 |
Acitretin in dermatology: a review.
Topics: Acitretin; Humans; Keratolytic Agents; Off-Label Use; Psoriasis; Skin Diseases; Skin Neoplasms | 2011 |
Nonmelanoma skin cancer chemoprevention.
Topics: Acitretin; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Deoxyribonuclease (Pyrimidine Dimer); Eflornithine; Humans; Monoterpenes; Peroxisome Proliferator-Activated Receptors; Photochemotherapy; Photosensitizing Agents; Polyphenols; Retinoids; Skin Neoplasms; Viral Proteins | 2011 |
Comparative tolerability of systemic treatments for plaque-type psoriasis.
Topics: Acitretin; Cyclosporine; Dermatologic Agents; Drug Combinations; Eye Diseases; Humans; Keratolytic Agents; Liver Cirrhosis; Lymphoproliferative Disorders; Methotrexate; Nausea; Pancytopenia; Pneumonia; Pruritus; Psoriasis; PUVA Therapy; Skin Neoplasms | 2002 |
Acitretin suppression of squamous cell carcinoma: case report and literature review.
Topics: Acitretin; Adult; Carcinoma, Squamous Cell; Humans; Keratolytic Agents; Male; Psoriasis; PUVA Therapy; Skin Neoplasms; Treatment Outcome | 2003 |
Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma.
Topics: Acitretin; Algorithms; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Drug Synergism; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; Treatment Outcome | 2003 |
Systemic and topical retinoids in the management of skin cancer in organ transplant recipients.
Topics: Acitretin; Administration, Oral; Administration, Topical; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Chemoprevention; Etretinate; Humans; Organ Transplantation; Precancerous Conditions; Retinoids; Skin Neoplasms | 2004 |
Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.
Topics: Acitretin; Administration, Oral; Humans; Organ Transplantation; Randomized Controlled Trials as Topic; Retinoids; Skin Neoplasms | 2005 |
Systemic retinoids in chemoprevention of non-melanoma skin cancer.
Topics: Acitretin; Administration, Oral; Chemoprevention; Dermatologic Agents; Dose-Response Relationship, Drug; Humans; Isotretinoin; Patient Selection; Retinoids; Skin Neoplasms | 2008 |
8 trial(s) available for acitretin and Cancer of Skin
Article | Year |
---|---|
Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).
Topics: Acitretin; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms, Second Primary; Placebos; Retinoids; Risk; Skin Neoplasms; Time Factors | 2012 |
Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients.
Topics: Acitretin; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cross-Over Studies; Female; Humans; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Skin Neoplasms | 2002 |
Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin.
Topics: Acitretin; Adult; Aged; Analysis of Variance; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunohistochemistry; Keratolytic Agents; Kidney Transplantation; Long-Term Care; Male; Middle Aged; Precancerous Conditions; Probability; Reference Values; Risk Assessment; Skin Neoplasms; Statistics, Nonparametric; Treatment Outcome | 2003 |
Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: Histologic and immunohistochemical effects.
Topics: Acitretin; Adult; Apoptosis; Biopsy; Carcinoma, Squamous Cell; Epidermal Cells; Epidermis; Female; Humans; Immunohistochemistry; Keratolytic Agents; Keratosis; Kidney Transplantation; Male; Middle Aged; Precancerous Conditions; Skin Neoplasms | 2004 |
Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
Topics: Acitretin; Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Imiquimod; Immunosuppression Therapy; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Ointments; Precancerous Conditions; Risk Factors; Skin; Skin Neoplasms | 2005 |
Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.
Topics: Acitretin; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chi-Square Distribution; Double-Blind Method; Female; Humans; Keratosis; Kidney Transplantation; Male; Middle Aged; Skin Neoplasms | 1995 |
Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
Topics: Acitretin; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Lymph Nodes; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Prospective Studies; PUVA Therapy; Recombinant Proteins; Remission Induction; Skin Neoplasms; Treatment Outcome | 1998 |
Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low-dose acitretin.
Topics: Acitretin; Adult; Aged; Humans; Immunocompromised Host; Keratolytic Agents; Kidney Transplantation; Middle Aged; Skin Neoplasms | 1999 |
101 other study(ies) available for acitretin and Cancer of Skin
Article | Year |
---|---|
Dihydroretinoic acids and their derivatives. Synthesis and biological activity.
Topics: Animals; Cells, Cultured; Cricetinae; Female; Mice; Neoplasms, Experimental; Organ Culture Techniques; Papilloma; RNA; Skin; Skin Neoplasms; Tretinoin; Vitamin A; Vitamin A Deficiency | 1977 |
Fluorinated retinoic acids and their analogues. 1. Synthesis and Biological activity of (4-methoxy-2,3,6-trimethylphenyl)nonatetraenoic acid analogues.
Topics: Animals; Mice; Neoplasms, Experimental; Papilloma; Skin Neoplasms; Structure-Activity Relationship; Tretinoin | 1979 |
A long-term cohort study of acitretin for prevention of keratinocyte carcinoma in solid organ transplant recipients.
Topics: Acitretin; Australia; Carcinoma, Squamous Cell; Cohort Studies; Humans; Keratinocytes; Organ Transplantation; Retrospective Studies; Skin Neoplasms | 2022 |
Acitretin enhances the cytotoxic effect of 5-aminolevulinic acid photodynamic therapy on squamous cell carcinoma cells.
Topics: Acitretin; Aminolevulinic Acid; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Skin Neoplasms | 2022 |
Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin.
Topics: Acitretin; Anticarcinogenic Agents; Bexarotene; Humans; Lymphoma, T-Cell, Cutaneous; Retrospective Studies; Skin Neoplasms; Tetrahydronaphthalenes | 2022 |
Treatment of Reactive Keratoacanthomas with Acitretin Following Multiple Excisions and Mohs Surgery for Recurrent Squamous Cell Carcinoma.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Keratoacanthoma; Mohs Surgery; Neoplasm Recurrence, Local; Skin Neoplasms | 2022 |
A case of successful treatment of concurrent verrucous epidermal naevi and psoriasis with apremilast.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Humans; Nevus, Sebaceous of Jadassohn; Psoriasis; Severity of Illness Index; Skin Neoplasms; Treatment Outcome | 2023 |
Mycosis Fungoides in Solid-Organ Transplant Recipients: A Multicenter Retrospective Cohort Study.
Topics: Acitretin; Adolescent; Child; Humans; Male; Mycosis Fungoides; Organ Transplantation; Prednisone; Retrospective Studies; Skin Neoplasms; Tacrolimus | 2023 |
Tache and talon noir in patient with mycosis fungoides on acitretin.
Topics: Acitretin; Humans; Mycosis Fungoides; Patients; Purpura; Skin Neoplasms | 2023 |
Education and Perspectives on the Use of Oral Skin Cancer Chemoprophylaxis: A Cross-Sectional Survey of Current Fellows in Mohs Micrographic Surgery & Dermatologic Oncology.
Topics: Acitretin; Cross-Sectional Studies; Curriculum; Education, Medical, Graduate; Educational Status; Fellowships and Scholarships; Humans; Mohs Surgery; Mouth Neoplasms; Niacinamide; Skin Neoplasms; Surveys and Questionnaires; United States | 2023 |
Monotherapy and combination therapy with acitretin for mycosis fungoides: results of a retrospective, multicentre study.
Topics: Acitretin; Female; Greece; Humans; Male; Mycosis Fungoides; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2020 |
Concurrent development of HIV-negative Kaposi's sarcoma and mycosis fungoides in an elderly Inuit from Canada.
Topics: Acitretin; Administration, Cutaneous; Aged, 80 and over; Anti-Inflammatory Agents; Herpesvirus 8, Human; Humans; Hydrocortisone; Immunocompromised Host; Immunosenescence; Inuit; Male; Mycosis Fungoides; Neoplasms, Multiple Primary; Sarcoma, Kaposi; Skin Neoplasms; Ultraviolet Therapy | 2021 |
Acitretin for Secondary Prevention of Keratinocyte Cancers in a Veteran Population: A Retrospective Cohort Study.
Topics: Acitretin; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Prescriptions; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Neoplasm Recurrence, Local; Retrospective Studies; Secondary Prevention; Skin; Skin Neoplasms; Veterans | 2021 |
Is the first-line systemic chemoprevention of nonmelanoma skin cancer nicotinamide or acitretin?
Topics: Acitretin; Chemoprevention; Humans; Niacinamide; Skin Neoplasms | 2021 |
Current Practices for Preventative Interventions for Nonmelanoma Skin Cancers Among Dermatologic Surgeons.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatologic Agents; Humans; Institutional Practice; Keratosis, Actinic; Mohs Surgery; Niacinamide; Practice Patterns, Physicians'; Private Practice; Skin Neoplasms; Surveys and Questionnaires; Vitamin B Complex | 2021 |
Systemic acitretin in the management of periocular squamous cell carcinoma.
Topics: Acitretin; Carcinoma, Squamous Cell; Humans; Skin Neoplasms | 2021 |
Low-Dose Acitretin for Secondary Prevention of Keratinocyte Carcinomas in Solid-Organ Transplant Recipients.
Topics: Acitretin; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cross-Over Studies; Female; Humans; Keratinocytes; Keratolytic Agents; Male; Middle Aged; Organ Transplantation; Postoperative Complications; Retrospective Studies; Secondary Prevention; Skin Neoplasms; Treatment Outcome | 2022 |
Acitretin amelioration of Acrokeratosis Paraneoplastica (Bazex Syndrome) in cases of incurable squamous cell carcinoma of the hypopharynx.
Topics: Acitretin; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Hypotrichosis; Keratolytic Agents; Male; Middle Aged; Paraneoplastic Syndromes; Skin Diseases; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2016 |
Superficial cutaneous hemorrhagic lesions in three mycosis fungoides patients using acitretin.
Topics: Acitretin; Aged; Female; Hemorrhage; Humans; Keratolytic Agents; Male; Middle Aged; Mycosis Fungoides; Skin Diseases; Skin Neoplasms | 2017 |
Paraneoplastic acrokeratosis (Bazex syndrome): unusual association with in situ follicular lymphoma and response to acitretin.
Topics: Acitretin; Carcinoma, Basal Cell; Diagnosis, Differential; Female; Foot; Hand; Humans; Hypotrichosis; Keratolytic Agents; Lymphoma, Follicular; Middle Aged; Skin Neoplasms | 2017 |
Acitretin-Altered Squamous Cell Carcinoma: A Pitfall in Diagnosis.
Topics: Acitretin; Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Humans; Keratolytic Agents; Male; Psoriasis; PUVA Therapy; Skin Neoplasms | 2019 |
Retinoic acid receptor agonist as monotherapy for early-stage mycosis fungoides: does it work?
Topics: Acitretin; Adolescent; Adult; Aged; Aged, 80 and over; Child; Dermatologic Agents; Female; Humans; Isotretinoin; Male; Middle Aged; Mycosis Fungoides; Retinoid X Receptors; Retrospective Studies; Skin Neoplasms; Young Adult | 2019 |
Combination therapy of sirolimus and acitretin in solid organ transplant recipients: a new cutaneous adverse event.
Topics: Acitretin; Aged; Carcinoma, Squamous Cell; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Organ Transplantation; Sirolimus; Skin Neoplasms; Transplant Recipients; Wound Healing | 2019 |
Granulomatous mycosis fungoides responsive to acitretin and UVA1 treatment.
Topics: Acitretin; Humans; Keratolytic Agents; Male; Middle Aged; Mycosis Fungoides; Skin Neoplasms; Ultraviolet Therapy | 2019 |
Acitretin combined with NB-UVB in the treatment of cutaneous CD30-positive anaplastic large cell lymphoma.
Topics: Acitretin; Aged; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Ki-1 Antigen; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Neoplasm Staging; Prognosis; Skin Neoplasms; Treatment Outcome; Ultraviolet Therapy | 2019 |
Hypo-pigmented mycosis fungoides is a rare malignancy in pediatrics.
Topics: Acitretin; Child; Fluocinolone Acetonide; Glucocorticoids; Humans; Hypopigmentation; Keratolytic Agents; Male; Mycosis Fungoides; Skin Neoplasms | 2018 |
A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil.
Topics: Acitretin; Aged; Antineoplastic Agents; Drug Therapy, Combination; Fluorouracil; Humans; Indoles; Injections, Intralesional; Keratoacanthoma; Keratolytic Agents; Male; Melanoma; Mutation; Neoplasm Metastasis; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Vemurafenib | 2013 |
Refractory adhesive capsulitis under acitretin therapy.
Topics: Acitretin; Adult; Arthroscopy; Bursitis; Female; Humans; Keratolytic Agents; Mycosis Fungoides; Skin Neoplasms | 2013 |
Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
Topics: Acitretin; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Immunosuppression Therapy; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Occupational Exposure; Prospective Studies; Skin Neoplasms; Sunlight; Tertiary Care Centers; Victoria | 2014 |
Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors.
Topics: Acitretin; Aged; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Cohort Studies; Female; Humans; Imidazoles; Indoles; Keratolytic Agents; Keratosis; Male; Melanoma; Middle Aged; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Vemurafenib | 2013 |
Complete and rapid regression of primary cutaneous follicular lymphoma with repeated oral administration of acitretin for palmoplantar psoriasis.
Topics: Acitretin; Administration, Oral; Follow-Up Studies; Humans; Keratolytic Agents; Lymphoma, Follicular; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Skin Neoplasms; Treatment Outcome | 2013 |
Vemurafenib-related cutaneous side effects ameliorated by acitretin.
Topics: Acitretin; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoprevention; Disease Progression; Female; Follow-Up Studies; Humans; Indoles; Keratolytic Agents; Melanoma; Middle Aged; Neoplasm Staging; Skin Neoplasms; Sulfonamides; Vemurafenib | 2014 |
Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.
Topics: Acitretin; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Deoxycytidine; Fatal Outcome; Fluorouracil; Graft vs Host Disease; Head and Neck Neoplasms; Histiocytoma, Malignant Fibrous; Humans; Keratolytic Agents; Lung Transplantation; Male; Skin Neoplasms | 2014 |
Dramatic clearance of HIV-associated bowenoid papulosis using combined oral acitretin and topical 5% imiquimod.
Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Adult; Aminoquinolines; Anal Canal; Antineoplastic Agents; Bowen's Disease; Drug Therapy, Combination; HIV Infections; Humans; Imiquimod; Keratolytic Agents; Male; Skin Neoplasms | 2014 |
Diffuse lichenplanopilaris and multiple squamous neoplasms.
Topics: Acitretin; Aged; Carcinoma, Squamous Cell; Dermatitis; Female; Humans; Hypertrophy; Keratoacanthoma; Keratolytic Agents; Lichen Planus; Skin Diseases; Skin Neoplasms | 2015 |
Targeting the adnexal epithelium: an unusual case of syringometaplasia in a patient on vemurafenib.
Topics: Acitretin; Aged; Biopsy; Cell Proliferation; Drug Eruptions; Eccrine Glands; Epithelial Cells; Humans; Indoles; Keratolytic Agents; Male; Melanoma; Metaplasia; Skin Neoplasms; Sulfonamides; Treatment Outcome; Vemurafenib | 2015 |
Serum Sirolimus Level Elevation Induced by Acitretin: Report of a Novel Drug-Drug Interaction.
Topics: Acitretin; Carcinoma, Squamous Cell; Drug Interactions; Humans; Immunosuppressive Agents; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Sirolimus; Skin Neoplasms | 2015 |
Case Report: Bazex Syndrome Associated With Pulmonary Adenocarcinoma.
Topics: Acitretin; Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Biopsy, Needle; Bone Neoplasms; Carcinoma, Basal Cell; Dexamethasone; Drug Therapy, Combination; Follow-Up Studies; Gefitinib; Humans; Hypotrichosis; Immunohistochemistry; Lung Neoplasms; Lymph Nodes; Male; Paraneoplastic Syndromes; Quinazolines; Radiography; Rare Diseases; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2016 |
Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
Topics: Acitretin; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Drug Resistance; Epidermodysplasia Verruciformis; Female; Gels; Humans; Imiquimod; Keratolytic Agents; Rare Diseases; Skin Neoplasms; Treatment Outcome; Tretinoin | 2016 |
Isolated sixth nerve palsy during acitretin treatment: a retinoid side effect or a mere coincidence?
Topics: Abducens Nerve; Acitretin; Administration, Oral; Aged; Diagnosis, Differential; Humans; Keratolytic Agents; Male; Paralysis; Skin Neoplasms | 2008 |
Acitretin induces apoptosis through CD95 signalling pathway in human cutaneous squamous cell carcinoma cell line SCL-1.
Topics: Acitretin; Apoptosis; Carcinoma, Squamous Cell; Caspases; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Fas Ligand Protein; fas Receptor; Fas-Associated Death Domain Protein; Gene Expression Regulation, Neoplastic; Humans; Protein Binding; RNA, Messenger; Signal Transduction; Skin Neoplasms | 2009 |
ILVEN: is it psoriasis? Debate based on successful treatment with etanercept.
Topics: Acitretin; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Dose-Response Relationship, Drug; Etanercept; Female; Humans; Immunoglobulin G; Keratolytic Agents; Nevus; Psoriasis; Receptors, Tumor Necrosis Factor; Skin Neoplasms | 2008 |
Recurrent keratoacanthoma with vascular invasion: a diagnostic and management dilemma.
Topics: Acitretin; Aged; Biopsy, Needle; Blood Vessels; Follow-Up Studies; Humans; Immunohistochemistry; Keratoacanthoma; Kidney Failure, Chronic; Knee; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Dialysis; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2009 |
Swiss clinical practice guidelines for skin cancer in organ transplant recipients.
Topics: Acitretin; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Humans; Immunocompromised Host; Organ Transplantation; Skin Neoplasms; Sunscreening Agents | 2009 |
Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins.
Topics: Acitretin; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorouracil; Forearm; Humans; Injections, Intralesional; Keratoacanthoma; Keratolytic Agents; Male; Methotrexate; Recurrence; Skin Neoplasms | 2009 |
Severe exacerbation of multiple self-healing squamous epithelioma (Ferguson-Smith disease) with radiotherapy, which was successfully treated with acitretin.
Topics: Acitretin; Carcinoma, Squamous Cell; Facial Neoplasms; Humans; Keratoacanthoma; Keratolytic Agents; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Neoplastic Syndromes, Hereditary; Skin Neoplasms | 2010 |
Poikilodermatous mycosis fungoides.
Topics: Acitretin; Antineoplastic Agents; Bexarotene; Female; Humans; Hydroxamic Acids; Hypopigmentation; Immunophenotyping; Interferon-alpha; Middle Aged; Mycosis Fungoides; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome; Ultraviolet Therapy; Vorinostat | 2010 |
Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin.
Topics: Acitretin; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms; Treatment Outcome | 2011 |
Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin.
Topics: Acitretin; Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms | 2011 |
[Oral acitretin and topical imiquimod as neoadjuvant treatment for giant basal cell carcinoma].
Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Aged; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Combined Modality Therapy; Facial Neoplasms; Female; Humans; Imiquimod; Neoadjuvant Therapy; Psoriasis; Remission Induction; Skin Neoplasms; Skin Ulcer; Thoracic Neoplasms | 2012 |
[Folliculosebaceous cystic hamartoma: anatomo-clinical study].
Topics: Acitretin; Adipocytes; Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Diagnosis, Differential; Epidermal Cyst; Facial Dermatoses; Female; Follicular Cyst; Hair Follicle; Hamartoma; Humans; Isotretinoin; Lasers, Gas; Male; Middle Aged; Neoplasms, Basal Cell; Radiodermatitis; Retrospective Studies; Skin Diseases; Skin Neoplasms; Stromal Cells; Young Adult | 2012 |
Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists.
Topics: Acitretin; Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Melanoma; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Skin Neoplasms; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
Systemic retinoid therapy for chemoprevention of nonmelanoma skin cancer in a patient treated with vemurafenib.
Topics: Acitretin; Aged; Carcinoma, Squamous Cell; Humans; Indoles; Keratolytic Agents; Male; Melanoma; Retinoids; Skin Neoplasms; Sulfonamides; Vemurafenib | 2012 |
Multiple eruptive squamous cell carcinoma in a patient with chronic plaque psoriasis on adalimumab.
Topics: Acitretin; Adalimumab; Aged; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Psoriasis; Skin Neoplasms | 2013 |
Acitretin for the treatment of cutaneous T-cell lymphoma.
Topics: Acitretin; Adult; Aged; Aged, 80 and over; Bexarotene; Female; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Retrospective Studies; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome | 2013 |
Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how.
Topics: Acitretin; Basal Cell Nevus Syndrome; Dermatologic Agents; Humans; Isotretinoin; Off-Label Use; Organ Transplantation; Psoriasis; Risk Factors; Skin Neoplasms; Sunlight; Xeroderma Pigmentosum | 2013 |
[Hexadactyly of hand and feet in a patient with basal cell nevus syndrome].
Topics: Acitretin; Adult; Basal Cell Nevus Syndrome; Fingers; Humans; Keratolytic Agents; Male; Skin; Skin Neoplasms; Toes | 2002 |
Acitretin for prophylaxis of cutaneous malignancies after cardiac transplantation.
Topics: Acitretin; Aged; Disease Progression; Heart Transplantation; Humans; Keratolytic Agents; Keratosis; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms | 2002 |
Multiple cutaneous squamous carcinoma in a psoriatic associated with ciclosporin, alcohol abuse and ultraviolet radiation exposure which were suppressed by acitretin.
Topics: Acitretin; Alcoholism; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppressive Agents; Keratolytic Agents; Leg; Male; Middle Aged; Psoriasis; PUVA Therapy; Skin Neoplasms; Ultraviolet Rays | 2003 |
Immunohistochemical effects of temporary cessation of long-term acitretin treatment in keratinocytic intraepidermal neoplasia of renal transplant recipients.
Topics: Acitretin; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Keratolytic Agents; Keratosis; Kidney Transplantation; Male; Middle Aged; Skin Neoplasms; Time Factors; Withholding Treatment | 2003 |
Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin.
Topics: Acitretin; Adult; Antiviral Agents; Carcinoma, Squamous Cell; Drug Therapy, Combination; Epidermodysplasia Verruciformis; Female; Humans; Interferon alpha-2; Interferon-alpha; Keratolytic Agents; Papillomaviridae; Recombinant Proteins; Skin Neoplasms | 2003 |
Successful treatment of multiple premalignant and malignant lesions in arsenical keratosis with a combination of acitretin and intralesional 5-fluorouracil.
Topics: Acitretin; Arsenic; Biopsy, Needle; Bowen's Disease; Carcinoma, Squamous Cell; Drug Therapy, Combination; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; India; Injections, Intralesional; Keratosis; Male; Middle Aged; Precancerous Conditions; Skin Neoplasms; Treatment Outcome; Water Pollutants | 2003 |
Arsenic-induced keratoses and Bowen's disease.
Topics: Acitretin; Arsenic Poisoning; Bowen's Disease; Humans; Keratolytic Agents; Keratosis; Male; Middle Aged; Skin Neoplasms | 2004 |
Effect of acitretin on wound healing in organ transplant recipients.
Topics: Acitretin; Administration, Oral; Adult; Aged; Anticarcinogenic Agents; Chemoprevention; Cohort Studies; Female; Humans; Immunocompromised Host; Male; Middle Aged; Organ Transplantation; Pilot Projects; Skin Neoplasms; Treatment Outcome; Wound Healing | 2004 |
A case of porokeratotic eccrine ostial and dermal duct naevus of late onset.
Topics: Acitretin; Adult; Diagnosis, Differential; Foot; Hand; Humans; Keratolytic Agents; Male; Nevus; Petrolatum; Porokeratosis; Salicylic Acid; Skin Neoplasms | 2004 |
Acitretin and skin cancer in kidney transplanted patients. Clinical and histological evaluation and immunohistochemical analysis of lymphocytes, natural killer cells and Langerhans' cells in sun exposed and sun protected skin.
Topics: Acitretin; Adult; Aged; Female; Humans; Keratolytic Agents; Keratosis; Kidney Transplantation; Killer Cells, Natural; Langerhans Cells; Lymphocytes; Male; Middle Aged; Skin Neoplasms; Sunlight; Ultraviolet Rays | 2005 |
[Effects of all-trans-retinoic acid, acitretin and tazarotene on apoptosis and Bax/Bcl-2 expressions of human melanoma cells A375 and the significance].
Topics: Acitretin; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Humans; Melanoma; Nicotinic Acids; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; Tretinoin; Tumor Cells, Cultured | 2005 |
Acitretin treatment of a systematized inflammatory linear verrucous epidermal naevus.
Topics: Acitretin; Administration, Oral; Adult; Diagnosis, Differential; Female; Humans; Keratolytic Agents; Nevus, Pigmented; Skin Neoplasms | 2005 |
Multiple squamous cell carcinomas in a patient with mycosis fungoides.
Topics: Acitretin; Carcinoma, Squamous Cell; Humans; Keratolytic Agents; Leg; Male; Middle Aged; Mycosis Fungoides; Neoplasms, Second Primary; Radiotherapy; Skin Neoplasms; Treatment Outcome | 2005 |
Aggressive undifferentiated squamous cell carcinoma in an immunosuppressed patient after kidney transplantation.
Topics: Acitretin; Adjuvants, Immunologic; Administration, Oral; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Counseling; Cyclosporine; Follow-Up Studies; Humans; Imiquimod; Immunocompromised Host; Immunosuppressive Agents; Keratolytic Agents; Keratosis; Kidney Transplantation; Male; Middle Aged; Ointments; Skin; Skin Neoplasms; Sunscreening Agents; Time Factors | 2005 |
[Acitretin induces apoptosis and changes of relative signaling pathway in epidermoid carcinoma cell line A431].
Topics: Acitretin; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Signal Transduction; Skin Neoplasms | 2006 |
Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects.
Topics: Acitretin; Chemoprevention; Humans; Keratolytic Agents; Monitoring, Physiologic; Retinoids; Skin Neoplasms | 2006 |
Folliculotropic mycosis fungoides with follicular mucinosis--case report.
Topics: Acitretin; Adrenal Cortex Hormones; Aged; Fatal Outcome; Humans; Male; Methotrexate; Mucinosis, Follicular; Mycosis Fungoides; PUVA Therapy; Skin Neoplasms | 2006 |
Multiple verrucous carcinomas treated with acitretin.
Topics: Acitretin; Adult; Carcinoma, Verrucous; Humans; Immunohistochemistry; Keratolytic Agents; Leg; Male; Proliferating Cell Nuclear Antigen; Skin Neoplasms; Staining and Labeling | 2007 |
A case of epidermodysplasia verruciformis with squamous cell carcinomas on non-sun-exposed areas of skin.
Topics: Acitretin; Adult; Carcinoma, Squamous Cell; Epidermodysplasia Verruciformis; Humans; Keratolytic Agents; Male; Skin Neoplasms; Skin Pigmentation | 2007 |
Folliculotropic mycosis fungoides.
Topics: Acitretin; Administration, Oral; Aged; Biopsy; Diagnosis, Differential; DNA, Neoplasm; Face; Follow-Up Studies; Gene Rearrangement, T-Lymphocyte; Humans; Immunohistochemistry; Keratolytic Agents; Male; Mycosis Fungoides; Neck; Receptors, Antigen, T-Cell; Scalp; Skin; Skin Neoplasms | 2007 |
Case of multiple verrucous carcinomas responding to treatment with acetretin more likely to have been a case of verrucous psoriasis.
Topics: Acitretin; Carcinoma, Verrucous; Diagnosis, Differential; Humans; Keratolytic Agents; Neoplasms, Second Primary; Psoriasis; Skin Neoplasms; Treatment Outcome; Warts | 2007 |
Acitretin and sixth nerve palsy.
Topics: Abducens Nerve; Acitretin; Aged; Diagnosis, Differential; Humans; Keratolytic Agents; Male; Paralysis; Skin Neoplasms | 2007 |
Successful treatment of palmoplantar arsenical keratosis with a combination of keratolytics and low-dose acitretin.
Topics: Acitretin; Arsenicals; Female; Foot Dermatoses; Hand Dermatoses; Humans; Keratoderma, Palmoplantar; Keratolytic Agents; Middle Aged; Skin Neoplasms; Treatment Outcome | 2008 |
Combining systemic retinoids with biologic agents for moderate to severe psoriasis.
Topics: Acitretin; Adalimumab; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Squamous Cell; Psoriasis; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Retrospective Studies; Serum Sickness; Skin Neoplasms; Treatment Outcome | 2008 |
An unusual cutaneous-polyposis syndrome stabilized with acitretin.
Topics: Acitretin; Adenomatous Polyps; Carcinoma, Squamous Cell; Female; Genes, Neoplasm; Humans; Intestinal Polyposis; Keratolytic Agents; Liver; Middle Aged; Skin Neoplasms; Syndrome; Treatment Outcome | 2008 |
[Antitumor effects of aromatic retinoids (Ro 10-1670, Ro 10-9359) on the chemically-induced epithelial tumors].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acitretin; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cricetinae; Etretinate; Mesocricetus; Mice; Neoplasms, Experimental; Papilloma; Skin Neoplasms; Tretinoin | 1982 |
Use of acitretin for the skin complications in renal transplant recipients.
Topics: Acitretin; Adult; Aged; Female; Humans; Keratosis; Kidney Transplantation; Male; Middle Aged; Skin Diseases; Skin Neoplasms; Warts | 1995 |
Treatment of cutaneous T-cell lymphoma by retinoids and calcitriol.
Topics: Acitretin; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Female; Humans; Isotretinoin; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Remission Induction; Skin Neoplasms | 1995 |
Treatment of cutaneous T-cell lymphoma by retinoids and calcitriol.
Topics: Acitretin; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Humans; Lymphoma, T-Cell, Cutaneous; Male; Skin Neoplasms; Treatment Outcome | 1995 |
Photopheresis in the red man or pre-Sézary syndrome.
Topics: Acitretin; Aged; Dermatitis, Exfoliative; Follow-Up Studies; Humans; Male; Mechlorethamine; Middle Aged; Photopheresis; Precancerous Conditions; Prednisone; Sezary Syndrome; Skin Neoplasms; Treatment Failure | 1995 |
Possible aggravation of hepatitis A by acitretin.
Topics: Acitretin; Hepatitis A; Hepatitis, Chronic; Humans; Male; Middle Aged; Mycosis Fungoides; Photochemotherapy; Skin Neoplasms | 1995 |
Remission of cutaneous T-cell lymphoma with combined calcitriol and acitretin.
Topics: Acitretin; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Female; Humans; Lymphoma, T-Cell, Cutaneous; Remission Induction; Skin Neoplasms | 1994 |
Milia during treatment of mycosis fungoides: follicular mycosis fungoides?
Topics: Acitretin; Humans; Mycosis Fungoides; Skin Diseases; Skin Neoplasms | 1994 |
Multiple milia during treatment with acitretin for mycosis fungoides.
Topics: Acitretin; Adult; Drug Eruptions; Hair Diseases; Humans; Male; Mycosis Fungoides; Skin Neoplasms | 1993 |
Keratoderma with scleroatrophy of the extremities or sclerotylosis (Huriez syndrome): a reappraisal.
Topics: Acitretin; Adult; Carcinoma, Squamous Cell; DNA Repair; Drug Therapy, Combination; Etretinate; Female; Genetic Linkage; Humans; Keratoderma, Palmoplantar; Keratolytic Agents; Male; Middle Aged; Pedigree; Skin Neoplasms | 1995 |
Successful treatment of papillomatosis cutis lymphostatica with acitretin.
Topics: Acitretin; Humans; Keratolytic Agents; Leg Dermatoses; Lymphedema; Male; Middle Aged; Papilloma; Skin Neoplasms; Thrombophlebitis; Venous Insufficiency | 1995 |
Multiple dermatofibromas in a patient with HIV infection.
Topics: Acitretin; Adult; Hemophilia B; Histiocytoma, Benign Fibrous; HIV Infections; Humans; Male; Prednisolone; Psoriasis; Skin Neoplasms; Ultraviolet Therapy | 1995 |
Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
Topics: Acitretin; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Middle Aged; Neoplasms, Multiple Primary; Psoriasis; PUVA Therapy; Skin Neoplasms | 1997 |
A case of verrucous epidermal naevus successfully treated with acitretin.
Topics: Acitretin; Administration, Oral; Adult; Capsules; Humans; Keratolytic Agents; Keratosis; Male; Nevus; Recurrence; Remission Induction; Skin Neoplasms; Warts | 1998 |
Acitretin for hypertrophic lichen planus-like reaction in a burn scar.
Topics: Acitretin; Biopsy; Burns; Carcinoma, Squamous Cell; Cicatrix, Hypertrophic; Diagnosis, Differential; Humans; Keratolytic Agents; Leg; Lichen Planus; Male; Middle Aged; Skin Neoplasms | 2000 |
[Follicular mycosis fungoides (FMF): a rare disease].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Keratolytic Agents; Male; Middle Aged; Mycosis Fungoides; Prognosis; PUVA Therapy; Skin; Skin Neoplasms; Time Factors | 2001 |
Treatment of arsenical keratosis and Bowen's disease with acitretin.
Topics: Acitretin; Aged; Arsenicals; Bowen's Disease; Female; Humans; Keratolytic Agents; Keratosis; Male; Skin Neoplasms | 2002 |
Cutaneous T cell lymphoma in a patient with primary biliary cirrhosis and secondary Sjögren's syndrome.
Topics: Acitretin; Biopsy, Needle; Female; Follow-Up Studies; Humans; Immunohistochemistry; Liver Cirrhosis, Biliary; Lymphoma, T-Cell, Cutaneous; Middle Aged; Mycosis Fungoides; PUVA Therapy; Sjogren's Syndrome; Skin Neoplasms; Treatment Outcome | 2002 |
Acitretin as cancer chemoprophylaxis in a renal transplant recipient.
Topics: Acitretin; Humans; Kidney Transplantation; Male; Middle Aged; Precancerous Conditions; Skin Neoplasms | 1992 |
Cutaneous metastasis from papillary carcinoma of the thyroid. A case confirmed by monoclonal antithyroglobulin antibody.
Topics: Acitretin; Antibodies, Monoclonal; Carcinoma, Papillary; Female; Humans; Immunoenzyme Techniques; Immunohistochemistry; Middle Aged; Skin Neoplasms; Thyroglobulin; Thyroid Neoplasms; Tretinoin | 1988 |